Clinical Trial Update: Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining safety and efficacy of SCT-I10A in head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• SCT-I10A

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN